Sue Ellen Verbrugge

Inactivating PSMB5 Mutations and P-Glycoprotein (Multidrug Resistance-Associated Protein/ATP-Binding Cassette B1) Mediate Resistance to Proteasome Inhibitors: Ex Vivo Efficacy of (Immuno)Proteasome Inhibitors in Mononuclear Blood Cells from Patients with Rheumatoid Arthritis

Sue Ellen Verbrugge, Yehuda G. Assaraf, Ben A. C. Dijkmans et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 107 citations

The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells

Luigi Maddaluno, Sue Ellen Verbrugge, Chiara Martinoli et al. · The Journal of Experimental Medicine · 2009 · 95 citations · Full text

Cell Adhesion, Immunology, Adhesion Molecule L1 +22

Effect of Noncompetitive Proteasome Inhibition on Bortezomib Resistance

Xiaoming Li, Tabitha E. Wood, Remco Sprangers et al. · JNCI Journal of the National Cancer Institute · 2010 · 76 citations · Full text

Multifactorial resistance to aminopeptidase inhibitor prodrug CHR2863 in myeloid leukemia cells: down-regulation of carboxylesterase 1, drug sequestration in lipid droplets and pro-survival activation ERK/Akt/mTOR

Sue Ellen Verbrugge, Marjon Al, Yehuda G. Assaraf et al. · Oncotarget · 2015 · 30 citations · Full text

Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors

Sue Ellen Verbrugge, Marjon Al, Yehuda G. Assaraf et al. · Experimental Hematology and Oncology · 2013 · 19 citations · Full text